OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic Review and Meta‐Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care
Francisco Martínez‐Mardones, Fernando Fernández-Llimós, Shalom I. Benrimoj, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 22
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain
Martin Schulz, Nina Griese‐Mammen, Uta Müller
International Journal of Clinical Pharmacy (2022) Vol. 45, Iss. 1, pp. 245-249
Open Access | Times Cited: 20

Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2)
Liuyun Wu, Ziyan Lv, Min Chen, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access

Remodeling arteries: studying the mechanical properties of 3D-bioprinted hybrid photoresponsive materials
Uxue Aizarna-Lopetegui, Clara García‐Astrain, Carlos Renero‐Lecuna, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 39, pp. 9431-9442
Open Access | Times Cited: 9

Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial
Malin Johansson Östbring, Tommy Eriksson, Göran Petersson, et al.
BMC Cardiovascular Disorders (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 19

Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease
Verughese Jacob, Jeffrey A. Reynolds, Sajal K. Chattopadhyay, et al.
American Journal of Preventive Medicine (2021) Vol. 62, Iss. 3, pp. e202-e222
Open Access | Times Cited: 16

Community pharmacists perception and role in the prevention and management of cardiovascular disease conditions: Evidence from Ghana
Amanda Henewaa Henneh, Philip Teg‐Nefaah Tabong
The International Journal of Health Planning and Management (2022) Vol. 37, Iss. 5, pp. 2794-2808
Closed Access | Times Cited: 8

Methodological standards for conducting and reporting meta-analyses: Ensuring the replicability of meta-analyses of pharmacist-led medication review
Aline de Fátima Bonetti, Fernanda S. Tonin, Rosa Camila Lucchetta, et al.
Research in Social and Administrative Pharmacy (2021) Vol. 18, Iss. 2, pp. 2259-2268
Closed Access | Times Cited: 10

Effects of pharmacist interventions on cardiovascular risk factors and outcomes: An umbrella review of meta‐analysis of randomized controlled trials
Wipharak Rattanavipanon, Thanaputt Chaiyasothi, Punyawee Puchsaka, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 7, pp. 3064-3077
Open Access | Times Cited: 7

Association between pharmacist-led telehealth services and improvements in cardiovascular outcomes among patients with cardiovascular risk factors: A scoping review
Arinze Nkemdirim Okere, Aliyah Balogun, Angela Smith, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2023) Vol. 19, pp. 200206-200206
Open Access | Times Cited: 3

Medication incident recovery and prevention utilising an Australian community pharmacy incident reporting system: the QUMwatch study
Khaled Adie, Romano A. Fois, Andrew J. McLachlan, et al.
European Journal of Clinical Pharmacology (2021) Vol. 77, Iss. 9, pp. 1381-1395
Closed Access | Times Cited: 7

Primary health care pharmacists and vision for community pharmacy and pharmacists in Chile
Francisco Martínez‐Mardones, Antonio Ahumada‐Canale, Loreto Gonzalez-Machuca, et al.
Pharmacy Practice (2020) Vol. 18, Iss. 3, pp. 2142-2142
Open Access | Times Cited: 6

BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial
Francisco Martínez‐Mardones, Shalom I. Benrimoj, Antonio Ahumada‐Canale, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 7, pp. 2131-2143
Open Access | Times Cited: 2

The Importance of Clinical Pharmacists in Improving Blood Glucose and Lipid Levels in Patients with Diabetes and Myocardial Infarction
Fang‐Hong Shi, Bin‐Bin Yu, Long Shen, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 2733-2744
Open Access | Times Cited: 2

Partnering With Pharmacists to Reduce Cardiovascular Risk in Outpatient Settings
Andrew Y. Hwang, Steven M. Smith
Journal of the American Heart Association (2019) Vol. 8, Iss. 22
Open Access | Times Cited: 4

Medication review with follow-up for cardiovascular outcomes: a trial based cost–utility analysis
Antonio Ahumada‐Canale, Constanza Vargas, Carlos Balmaceda, et al.
Journal of Comparative Effectiveness Research (2021) Vol. 10, Iss. 3, pp. 229-242
Closed Access | Times Cited: 4

Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model
Antonio Ahumada‐Canale, Constanza Vargas, Francisco Martínez‐Mardones, et al.
Health Policy (2021) Vol. 125, Iss. 11, pp. 1406-1414
Open Access | Times Cited: 4

Pharmacist-led cardiovascular risk prevention in Western Canada: a qualitative study
Anita Kapanen, Annalijn Conklin, Barbara Gobis, et al.
International Journal of Pharmacy Practice (2020) Vol. 29, Iss. 1, pp. 45-54
Closed Access | Times Cited: 3

Clinical pharmacy services in Brazil, particularly cardiometabolic diseases: a systematic scoping review and meta-analyses
Priscila L Nassur, Marcela Forgerini, Patrícia de Carvalho Mastroianni, et al.
Pharmacy Practice (2020) Vol. 18, Iss. 4, pp. 2131-2131
Open Access | Times Cited: 3

Pharmacist-led medication reviews: A scoping review of systematic reviews
M E Craske, Wendy Hardeman, Nicholas Steel, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

Pharmacist-led medication reviews: A scoping review of systematic reviews
M E Craske, Wendy Hardeman, Nicholas Steel, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0309729-e0309729
Open Access

Bridging the gap: Enhancing pharmacist-physiscian collaboration through provided comprehensive medication reviews in the community pharmacy in Spain
Ana I. Sanchez-Molina, Shalom I. Benrimoj, Ramón Ferri‐García, et al.
Exploratory Research in Clinical and Social Pharmacy (2024) Vol. 17, pp. 100555-100555
Open Access

A shared decision‐making intervention by pharmacy students to improve statin adherence
Nicole A. Osbaugh, Sarah J. Billups
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2021) Vol. 5, Iss. 1, pp. 34-41
Closed Access | Times Cited: 1

Hypertension management and drug-related problems. A case report of the 23-year history of Mr. Jonas
Indrė Trečiokienė, Jūratė Pečeliūnienė, Björn Wettermark, et al.
Exploratory Research in Clinical and Social Pharmacy (2023) Vol. 11, pp. 100313-100313
Open Access

Peripheral Arterial Disease and the Pharmacist’s Role in Management
Zachary A. Stacy
Journal of Clinical Pharmacy and Therapeutics (2023) Vol. 2023, pp. 1-12
Open Access

Page 1 - Next Page

Scroll to top